Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can Patients With Residual Cancer After Chemotherapy for Early Breast Cancer be Identified With Multiple Ultrasound-guided Biopsies?

NCT04118192 is registered in ClinicalTrials.gov with University of Birmingham as lead sponsor.

NCT NCT04118192
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04118192 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can Patients With Residual Cancer After Chemotherapy for Early Breast Cancer be Identified With Multiple Ultrasound-guided Biopsies?
Lead sponsor
University of Birmingham
Phase
Observational
Overall status
Active, not recruiting
Start date
May 22, 2019
Completion date
December 31, 2025
Enrollment
72 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer